Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial
Titel:
Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial
Auteur:
Rini, Brian I. Quinn, David I. Baum, Michael Wood, Laura S. Tarazi, Jamal Rosbrook, Brad Arruda, Lillian Shahied Cisar, Laura Roberts, W. Gregory Kim, Sinil Motzer, Robert J.